About: http://data.cimple.eu/news-article/ccd2327f4c39ccb4c38af5f89df5b0289b2bb3e1928891682eae23d0

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/ccd2327f4c39ccb4c38af5f89df5b0289b2bb3e1928891682eae23d0 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	South Africa on Tuesday suspended the rollout of the Johnson & Johnson Covid-19 vaccine over potential blood clot risks reported by the United States, the health minister said. The announcement delays an already sluggish vaccination campaign in Africa's worst-hit country, which has so far only administered the US-made jab. "We have determined to voluntarily suspend our rollout until the causal relationship between the development of clots and the Johnson & Johnson vaccine is sufficiently interrogated," Health Minister Zweli Mkhize announced in an online press briefing. The US Food and Drug Administration (FDA) and the Centers for Disease Control earlier on Tuesday recommended a pause in the use of the single shot J&J vaccine over potential links to a rare type of blood clot. US health authorities took the action "out of an abundance of caution", but J&J has since delayed the rollout of its jab in Europe. Mkhize said that although no blood clots had been reported among vaccinated citizens in South Africa, the FDA's advice should not be taken "lightly". "We hope that the deliberations will only take a few days," he added. "Given the preliminary literature at hand our scientists are confident that the FDA decision is only on a precautionary basis, and we expect that this will not result in the complete withdrawal of the Johnson & Johnson vaccine." South Africa has vaccinated just under 290,000 health workers since February 17. The second phase of the country's rollout plan, which will target essential workers and over-60s, is scheduled to begin on May 17. Authorities had already been forced to scrap plans to start vaccinating with the Oxford/AstraZeneca jab after a study suggested the formula was less effective against a dominant local virus strain. So far South Africa has secured 31 million doses from J&J and 30 million from Pfizer, which are yet to be delivered. Another 1.2 million doses will be donated by the international vaccine sharing facility Covax, and an undisclosed amount from the African Union. sch/kjl
schema:headline	S.Africa suspends J&J vaccine rollout over blood clot concerns
schema:mentions	Johnson & Johnson Thrombus Jab Ebola virus disease University of Oxford Africa AstraZeneca Food and Drug Administration South Africa European Union Pfizer Vaccine United States Coronavirus disease 2019 Precautionary principle Zweli Mkhize
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-04-13 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	82 (xsd:integer)
http://data.cimple...tology#hasEmotion	fear

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software